Meloxicam and Cysteine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Meloxicam (meloxicam) and Cysteine (n - acetyl cysteine). Common drug interactions include sinusitis among females and craniocerebral injury among males.
The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Cysteine. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.
What is Meloxicam?
Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.
What is Cysteine?
Cysteine has active ingredients of n - acetyl cysteine. eHealthMe is studying from 1,755 Cysteine users. Check the latest studies of Cysteine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
42 people who take Meloxicam and Cysteine together, and have interactions are studied.

What are the common drug interactions of Meloxicam and Cysteine, by gender? *:
female:
- Sinusitis (inflammation of sinus)
- Alopecia (absence of hair from areas of the body)
- Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
- Chronic fatigue syndrome (disorder that causes extreme fatigue)
- Inflammation
- Irritable bowel syndrome
- Malaise (a feeling of general discomfort or uneasiness)
- Ocular hyperaemia (an abnormally large amount of blood in eye)
- Blood pressure fluctuation
- Blood pressure increased
male:
- Craniocerebral injury (injury to cranium and brain)
- Apnoea (suspension of external breathing)
- Nervousness
- Road traffic accident
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Spinal fracture (fracture in one of vertebrae)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Alopecia (absence of hair from areas of the body)
- Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
- Attention deficit/hyperactivity disorder
What are the common drug interactions of Meloxicam and Cysteine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Breast mass
- Diarrhoea
- Dizziness
- Hyperhidrosis (abnormally increased sweating)
- Malaise (a feeling of general discomfort or uneasiness)
- Sinusitis (inflammation of sinus)
30-39:
n/a
40-49:
n/a
50-59:
- Alopecia (absence of hair from areas of the body)
- Inflammation
- Sinusitis (inflammation of sinus)
- Apnoea (suspension of external breathing)
- Bladder obstruction
- Blood pressure fluctuation
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Muscle spasms (muscle contraction)
- Road traffic accident
- Sedation
60+:
- Anaemia (lack of blood)
- Chills (felling of cold)
- Megacolon (a very dilated colon)
- Pyrexia (fever)
- Respiratory tract infection
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Colitis (inflammation of colon)
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Death
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 26 people, 61.90%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 12 people, 28.57%
- Pain: 6 people, 14.29%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 9.52%
- Immunodeficiency Common Variable: 4 people, 9.52%
- Immunodeficiency: 4 people, 9.52%
- Hypersensitivity: 3 people, 7.14%
- Drowsiness: 3 people, 7.14%
- Asthma: 3 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Meloxicam and Cysteine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Meloxicam and Cysteine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meloxicam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cysteine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meloxicam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cysteine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam and n - acetyl cysteine (the active ingredients of Meloxicam and Cysteine, respectively), and Meloxicam and Cysteine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Neuralgia and Panic Disorder - 4 seconds ago
- Drug interactions of Diphenhydramine Hydrochloride and Tylenol W/ Codeine - 12 seconds ago
- Could Claritin cause Rheumatoid Arthritis? - 14 seconds ago
- Drug interactions of Warfarin Sodium and Glucophage - 18 seconds ago
- Could Letairis cause Ovarian Cysts? - 38 seconds ago
- Could Azithromycin cause Urticaria? - 43 seconds ago
- Could Azithromycin cause Bone Disorder? - 48 seconds ago
- Could Glipizide cause Salivary Hypersecretion? - 48 seconds ago
- Could Avalide cause Back Pain? - a minute ago
- Could Atenolol cause Arterial Injury? - a minute ago